We are live on
!
Find out more
IVM
InterWest Venture Management Portfolio holdings
AUM
$20.6M
1-Year Est. Return
48.5%
This Fund
S&P 500
This Quarter
Est. Return
-32.74%
1 Year Est. Return
+48.5%
3 Year Est. Return
-57.65%
5 Year Est. Return
-76.52%
10 Year Est. Return
–
AUM
$71.2M
AUM Growth
-$134M
(-65%)
Cap. Flow
-$101M
Cap. Flow
% of AUM
-141.31%
Top 10 Holdings %
Top 10 Hldgs %
99.93%
Holding
11
New
–
Increased
–
Reduced
2
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSRO
TESARO, Inc.
TSRO
|
+$96.8M |
| 2 |
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
|
+$3.85M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
RCP
LUGPI
SIC
DOS
AA
CVSCT
VNB
BEP
InterWest Venture Management's Q4 2018 Portfolio in Review
As of Q4 2018, InterWest Venture Management held 11 positions worth $71.2M, down 65% from $205M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
InterWest Venture Management withdrew a net $101M in Q4 2018, reducing 2 holdings. Its largest reduction was TESARO, Inc., cutting an estimated $96.8M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- InterWest Venture Management's biggest Q4 2018 reduction was TESARO, Inc., cutting an estimated $96.8M.
- InterWest Venture Management's ten largest holdings make up 100% of its $71.2M portfolio in Q4 2018.
- InterWest Venture Management opened 0 new positions and closed 0 in Q4 2018.
- InterWest Venture Management's portfolio value fell 65% quarter-over-quarter to $71.2M.
Based on InterWest Venture Management's 13F filing for Q4 2018, filed 4 Jan 2019.